Aclarion closes $10.4M equity offering, reports $21.6M cash, zero debt, runway into 2028

Aclarion, Inc.

Closed $10.4M common-stock-only offering at $5.18/share; includes 200,000 shares and pre-funded warrants for 1.8M shares.
Cash balance $21.6M as of Jan 12, 2026; zero debt.
Cash runway extended into 2028 based on current operating plans.
Plans to accelerate CLARITY trial enrollment, launch Nociscan v2.8 in Q1'26, and pursue payer coverage.
Dawson James Securities acted as exclusive placement agent.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.